1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Central Nervous System (CNS) Therapeutics Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Disease
6.1 Neurodegenerative Diseases
6.1.1 Market Trends
6.1.2 Key Segments
6.1.2.1 Alzheimer's Disease
6.1.2.2 Parkinson’s Disease
6.1.2.3 Multiple Sclerosis
6.1.2.4 Huntington's Disease
6.1.2.5 Amyotrophic Lateral Sclerosis
6.1.2.6 Others
6.1.3 Market Forecast
6.2 Neurovascular Diseases
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 CNS Trauma
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Mental Health
6.4.1 Market Trends
6.4.2 Key Segments
6.4.2.1 Anxiety Disorders
6.4.2.2 Epilepsy
6.4.2.3 Mood Disorders
6.4.2.4 Psychotic Disorders
6.4.2.5 Others
6.4.3 Market Forecast
6.5 Infectious Diseases
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 CNS Cancer
6.6.1 Market Trends
6.6.2 Market Forecast
6.7 Others
6.7.1 Market Trends
6.7.2 Market Forecast
7 Market Breakup by Application
7.1 Hospital
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Clinic
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Homecare
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Others
7.4.1 Market Trends
7.4.2 Market Forecast
8 Market Breakup by Region
8.1 North America
8.1.1 United States
8.1.1.1 Market Trends
8.1.1.2 Market Forecast
8.1.2 Canada
8.1.2.1 Market Trends
8.1.2.2 Market Forecast
8.2 Asia-Pacific
8.2.1 China
8.2.1.1 Market Trends
8.2.1.2 Market Forecast
8.2.2 Japan
8.2.2.1 Market Trends
8.2.2.2 Market Forecast
8.2.3 India
8.2.3.1 Market Trends
8.2.3.2 Market Forecast
8.2.4 South Korea
8.2.4.1 Market Trends
8.2.4.2 Market Forecast
8.2.5 Australia
8.2.5.1 Market Trends
8.2.5.2 Market Forecast
8.2.6 Indonesia
8.2.6.1 Market Trends
8.2.6.2 Market Forecast
8.2.7 Others
8.2.7.1 Market Trends
8.2.7.2 Market Forecast
8.3 Europe
8.3.1 Germany
8.3.1.1 Market Trends
8.3.1.2 Market Forecast
8.3.2 France
8.3.2.1 Market Trends
8.3.2.2 Market Forecast
8.3.3 United Kingdom
8.3.3.1 Market Trends
8.3.3.2 Market Forecast
8.3.4 Italy
8.3.4.1 Market Trends
8.3.4.2 Market Forecast
8.3.5 Spain
8.3.5.1 Market Trends
8.3.5.2 Market Forecast
8.3.6 Russia
8.3.6.1 Market Trends
8.3.6.2 Market Forecast
8.3.7 Others
8.3.7.1 Market Trends
8.3.7.2 Market Forecast
8.4 Latin America
8.4.1 Brazil
8.4.1.1 Market Trends
8.4.1.2 Market Forecast
8.4.2 Mexico
8.4.2.1 Market Trends
8.4.2.2 Market Forecast
8.4.3 Others
8.4.3.1 Market Trends
8.4.3.2 Market Forecast
8.5 Middle East and Africa
8.5.1 Market Trends
8.5.2 Market Breakup by Country
8.5.3 Market Forecast
9 SWOT Analysis
9.1 Overview
9.2 Strengths
9.3 Weaknesses
9.4 Opportunities
9.5 Threats
10 Value Chain Analysis
11 Porters Five Forces Analysis
11.1 Overview
11.2 Bargaining Power of Buyers
11.3 Bargaining Power of Suppliers
11.4 Degree of Competition
11.5 Threat of New Entrants
11.6 Threat of Substitutes
12 Price Analysis
13 Competitive Landscape
13.1 Market Structure
13.2 Key Players
13.3 Profiles of Key Players
13.3.1 AstraZeneca plc
13.3.1.1 Company Overview
13.3.1.2 Product Portfolio
13.3.1.3 Financials
13.3.1.4 SWOT Analysis
13.3.2 Biogen Inc.
13.3.2.1 Company Overview
13.3.2.2 Product Portfolio
13.3.2.3 Financials
13.3.2.4 SWOT Analysis
13.3.3 Eli Lilly and Company
13.3.3.1 Company Overview
13.3.3.2 Product Portfolio
13.3.3.3 Financials
13.3.3.4 SWOT Analysis
13.3.4 F. Hoffmann-La Roche AG (Roche Holding)
13.3.4.1 Company Overview
13.3.4.2 Product Portfolio
13.3.4.3 SWOT Analysis
13.3.5 H. Lundbeck A/S
13.3.5.1 Company Overview
13.3.5.2 Product Portfolio
13.3.5.3 Financials
13.3.5.4 SWOT Analysis
13.3.6 Merck & Co. Inc.
13.3.6.1 Company Overview
13.3.6.2 Product Portfolio
13.3.6.3 Financials
13.3.6.4 SWOT Analysis
13.3.7 Neurocrine Biosciences Inc.
13.3.7.1 Company Overview
13.3.7.2 Product Portfolio
13.3.7.3 Financials
13.3.7.4 SWOT Analysis
13.3.8 Novartis AG
13.3.8.1 Company Overview
13.3.8.2 Product Portfolio
13.3.8.3 Financials
13.3.8.4 SWOT Analysis
13.3.9 Pfizer Inc.
13.3.9.1 Company Overview
13.3.9.2 Product Portfolio
13.3.9.3 Financials
13.3.9.4 SWOT Analysis
13.3.10 Sanofi S.A.
13.3.10.1 Company Overview
13.3.10.2 Product Portfolio
13.3.10.3 Financials
13.3.10.4 SWOT Analysis
13.3.11 Takeda Pharmaceutical Company Limited
13.3.11.1 Company Overview
13.3.11.2 Product Portfolio
13.3.11.3 Financials
13.3.11.4 SWOT Analysis
13.3.12 Teva Pharmaceutical Industries Ltd.
13.3.12.1 Company Overview
13.3.12.2 Product Portfolio
13.3.12.3 Financials
13.3.12.4 SWOT Analysis
List of Figures
Figure 1: Global: Central Nervous System Therapeutics Market: Major Drivers and Challenges
Figure 2: Global: Central Nervous System Therapeutics Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: Central Nervous System Therapeutics Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 4: Global: Central Nervous System Therapeutics Market: Breakup by Disease (in %), 2024
Figure 5: Global: Central Nervous System Therapeutics Market: Breakup by Application (in %), 2024
Figure 6: Global: Central Nervous System Therapeutics Market: Breakup by Region (in %), 2024
Figure 7: Global: Central Nervous System Therapeutics (Neurodegenerative Diseases) Market: Sales Value (in Million USD), 2019 & 2024
Figure 8: Global: Central Nervous System Therapeutics (Neurodegenerative Diseases) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 9: Global: Central Nervous System Therapeutics (Neurovascular Diseases) Market: Sales Value (in Million USD), 2019 & 2024
Figure 10: Global: Central Nervous System Therapeutics (Neurovascular Diseases) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 11: Global: Central Nervous System Therapeutics (CNS Trauma) Market: Sales Value (in Million USD), 2019 & 2024
Figure 12: Global: Central Nervous System Therapeutics (CNS Trauma) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 13: Global: Central Nervous System Therapeutics (Mental Health) Market: Sales Value (in Million USD), 2019 & 2024
Figure 14: Global: Central Nervous System Therapeutics (Mental Health) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 15: Global: Central Nervous System Therapeutics (Infectious Diseases) Market: Sales Value (in Million USD), 2019 & 2024
Figure 16: Global: Central Nervous System Therapeutics (Infectious Diseases) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 17: Global: Central Nervous System Therapeutics (CNS Cancer) Market: Sales Value (in Million USD), 2019 & 2024
Figure 18: Global: Central Nervous System Therapeutics (CNS Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 19: Global: Central Nervous System Therapeutics (Other Diseases) Market: Sales Value (in Million USD), 2019 & 2024
Figure 20: Global: Central Nervous System Therapeutics (Other Diseases) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 21: Global: Central Nervous System Therapeutics (Hospital) Market: Sales Value (in Million USD), 2019 & 2024
Figure 22: Global: Central Nervous System Therapeutics (Hospital) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 23: Global: Central Nervous System Therapeutics (Clinic) Market: Sales Value (in Million USD), 2019 & 2024
Figure 24: Global: Central Nervous System Therapeutics (Clinic) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 25: Global: Central Nervous System Therapeutics (Homecare) Market: Sales Value (in Million USD), 2019 & 2024
Figure 26: Global: Central Nervous System Therapeutics (Homecare) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 27: Global: Central Nervous System Therapeutics (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
Figure 28: Global: Central Nervous System Therapeutics (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 29: North America: Central Nervous System Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 30: North America: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 31: United States: Central Nervous System Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 32: United States: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 33: Canada: Central Nervous System Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 34: Canada: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 35: Asia-Pacific: Central Nervous System Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 36: Asia-Pacific: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 37: China: Central Nervous System Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 38: China: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 39: Japan: Central Nervous System Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 40: Japan: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 41: India: Central Nervous System Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 42: India: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 43: South Korea: Central Nervous System Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 44: South Korea: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 45: Australia: Central Nervous System Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 46: Australia: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 47: Indonesia: Central Nervous System Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 48: Indonesia: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 49: Others: Central Nervous System Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 50: Others: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 51: Europe: Central Nervous System Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 52: Europe: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 53: Germany: Central Nervous System Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 54: Germany: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 55: France: Central Nervous System Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 56: France: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 57: United Kingdom: Central Nervous System Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 58: United Kingdom: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 59: Italy: Central Nervous System Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 60: Italy: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 61: Spain: Central Nervous System Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 62: Spain: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 63: Russia: Central Nervous System Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 64: Russia: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 65: Others: Central Nervous System Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 66: Others: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 67: Latin America: Central Nervous System Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 68: Latin America: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 69: Brazil: Central Nervous System Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 70: Brazil: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 71: Mexico: Central Nervous System Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 72: Mexico: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 73: Others: Central Nervous System Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 74: Others: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 75: Middle East and Africa: Central Nervous System Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 76: Middle East and Africa: Central Nervous System Therapeutics Market: Breakup by Country (in %), 2024
Figure 77: Middle East and Africa: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 78: Global: Central Nervous System Therapeutics Industry: SWOT Analysis
Figure 79: Global: Central Nervous System Therapeutics Industry: Value Chain Analysis
Figure 80: Global: Central Nervous System Therapeutics Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Central Nervous System Therapeutics Market: Key Industry Highlights, 2024 and 2033
Table 2: Global: Central Nervous System Therapeutics Market Forecast: Breakup by Disease (in Million USD), 2025-2033
Table 3: Global: Central Nervous System Therapeutics Market Forecast: Breakup by Application (in Million USD), 2025-2033
Table 4: Global: Central Nervous System Therapeutics Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 5: Global: Central Nervous System Therapeutics Market: Competitive Structure
Table 6: Global: Central Nervous System Therapeutics Market: Key Players